A Program at Risk
The 340B program was created to help hospitals, clinics, and care centers provide care for vulnerable populations and underserved communities. Drug companies provide steep discounts on prescription medication, and in return, 340B health care centers called covered entities reinvest savings into affordable medicines and patient services. But evidence suggests covered entities often fail to live up to that promise. 340B is off track, and it’s at risk.
The initiative serves as a platform for stakeholders to:
-
Engage in policy discussions about the drug discount program.
-
Raise awareness about the negative impacts of expanding the broken system.
-
Encourage policymakers to take a balanced patient-centered approach to 340B policy.
Recent resources
Senators Agree: 340B Is Broken and Must Be Reformed
October 29, 2025
An October hearing held by the U.S. Senate HELP Committee delivered bipartisan calls for both preservation and reform. At first glance, those two goals may seem at odds with each other. But when it comes to 340B, reform may be what’s needed to preserve the program for the future.
